Responses
Clinical and epidemiological research
Extended report
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)
Compose a Response to This Article
Other responses
No responses have been published for this article.